4/A//SEC Filing
Favet Michael 4/A
Accession 0001209191-21-043744
CIK 0001528287other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 6:12 PM ET
Size
7.8 KB
Accession
0001209191-21-043744
Insider Transaction Report
Form 4/AAmended
NeuroPace IncNPCE
Favet Michael
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-06-04+27,000→ 27,000 total - Award
Stock Option (Right to Buy)
2021-06-04+54,000→ 54,000 totalExercise: $21.67From: 2021-06-04Exp: 2031-06-03→ Common Stock (54,000 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.
Documents
Issuer
NeuroPace Inc
CIK 0001528287
Entity typeother
Related Parties
1- filerCIK 0001855656
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 6:12 PM ET
- Size
- 7.8 KB